Inflammatory and Immune Mechanisms of Atherosclerosis in HIV-Infected Women

HIV感染女性动脉粥样硬化的炎症和免疫机制

• 批准号: 8107527
• 负责人: Robert C Kaplan
• 金额: $ 83.66万
• 依托单位: ALBERT EINSTEIN COLLEGE OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-09-25 至 2013-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8107527
• 关键词: Address; Adult; Adverse effects; Affect; African American; Anti-Inflammatory Agents; Anti-inflammatory; Apolipoprotein E; Appearance; Area; Arterial Fatty Streak; Aspirin; Atherosclerosis; Bacterial Translocation; Biological Markers; Biological Response Modifiers; Biometry; Blood Circulation; Blood Vessels; Blood coagulation; CCR5 gene; CD28 gene; CD4 Lymphocyte Count; CD8B1 gene; Cardiology; Cardiovascular Diseases; Carotid Arteries; Cell Aging; Cell surface; Cells; Chronic; Clinical; Clinical Trials; Coagulation Process; Cohort Studies; Coronary Arteriosclerosis; Coronary heart disease; Cross-Sectional Studies; Data; Data Analyses; Development; Discipline; Disease; Disease Pathway; Elderly; Employee Strikes; Etiology; Event; Fatty acid glycerol esters; Fibrin fragment D; Functional disorder; Goals; Grant; HIV; HIV Infections; HIV Seropositivity; Highly Active Antiretroviral Therapy; Hispanics; Image; Immune; Immune System Diseases; Immunology; Individual; Infection; Inflammation; Inflammation Mediators; Inflammatory; Interdisciplinary Study; Interferons; Interleukin-10; Interleukin-12; Interleukin-4; Interleukin-6; Internet; Investigation; Leadership; Link; Lipids; Lipoproteins; Longitudinal Studies; Measurement; Measures; Mediator of activation protein; Metabolic; Metabolic Diseases; Microbe; Minority; Monitor; Mus; Pathway interactions; Patients; Peripheral; Phase; Phenotype; Play; Population; RNA; Recruitment Activity; Regulatory T-Lymphocyte; Research Infrastructure; Research Personnel; Risk; Risk Factors; Role; Severity of illness; Specimen; Staging; Surface; System; T cell response; T-Cell Depletion; T-Lymphocyte; TNF gene; Thick; Time; Toxic effect; Ultrasonography; Universities; Ursidae Family; Vascular Diseases; Vermont; Very low density lipoprotein; Viral Load result; Viremia; Woman; Work; abstracting; cardiovascular disorder risk; chemokine; cohort; cytokine; disease phenotype; exhaustion; experience; follow-up; illness length; immune activation; immune function; improved; innovation; insight; intima media; lipid metabolism; longitudinal design; novel; pathogen; prospective; response; senescence; toll-like receptor 4; virology

DESCRIPTION (provided by applicant): This investigation will examine immune, inflammatory, coagulation, and lipid disturbances as potential mediators of increased atherosclerosis in HIV-infected women participating in the Women's Interagency HIV Study (WIHS). Subjects will include 750 HIV-infected and 250 HIV-uninfected women participating in the Follow-up Phase of the WIHS Carotid Artery Ultrasound Study. The set of specific aims include two primary aims: Aim 1 focuses on established inflammation and coagulation biomarkers as predictors of subclinical atherosclerosis. Aim 2 examines lipid changes which constitute "classic" vascular risk factors. Data analysis goals are: (1) To correlate changes in inflammatory and coagulation markers with HIV disease stage and treatments, including initiation of HAART and changes in viremic and CD4+ status; (2) To determine if immune, inflammatory, and coagulation mechanisms contribute to increased atherosclerosis in HIV-infected women; (3) To determine changes in "classic" vascular risk factors (e.g., lipids) over time due to changes in HAART and HIV disease stage, and how this impacts atherosclerosis. In addition, we propose three exploratory aims examining novel immune and inflammatory mediators that may be of importance to atherosclerosis in HIV-infected adults: 1. Translocation of gut microbes, as measured by 16s RNA; 2. T-cell senescence (CD4+CD28- and CD8+CD28- T-cells); 3. T regulatory cells. This investigation will examine immune, inflammatory, coagulation, and lipid disturbances as potential mediators of increased atherosclerosis in HIV-infected women participating in the Women's Interagency HIV Study (WIHS). We will (1) correlate changes in inflammatory and coagulation markers with HIV disease stage and treatments, including initiation of HAART and changes in viremic and CD4+ status; (2) determine if immune, inflammatory, and coagulation mechanisms contribute to increased atherosclerosis in HIV-infected women; and (3) determine changes in "classic" vascular risk factors (e.g., lipids) over time due to changes in HAART and HIV disease stage, and how this impacts atherosclerosis. (End of Abstract)

描述（由申请人提供）：